Epidemiological shifts and clinical characteristics of childhood Chlamydia pneumoniae pneumonia in Beijing before, during, and after public health interventions (2017–2025)
BMC Infectious Diseases·
- DOI
- 10.1186/s12879-026-13779-5
- PMID
- 42298460
- PMCID
- —
- OpenAlex
- W7164820373
- Study type
- Cohort study
- Publisher
- Springer Science and Business Media LLC
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Findings suggest a 'suppression-rebound' effect of NPIs on childhood Chlamydia pneumoniae pneumonia, with a shift toward school-aged children and implications for targeted school-based prevention and optimized antibiotic treatment.
Structured evidence summary
Research question
The study examined how population-level public health non-pharmaceutical interventions (NPIs) and their subsequent relaxation influenced the epidemiological trends and clinical characteristics of childhood Chlamydia pneumoniae pneumonia in Beijing.
Study design
A retrospective cohort study of 331 hospitalized children with laboratory-confirmed Chlamydia pneumoniae pneumonia, stratified into pre-, during-, and post-intervention groups based on NPI intensity in Beijing from January 2017 to September 2025.
Population and setting
Hospitalized children with laboratory-confirmed Chlamydia pneumoniae pneumonia treated at the Capital Center for Children's Health in Beijing, with a male-to-female ratio of 1.75:1; cases were drawn from a community-acquired pneumonia population.
Main findings
A marked surge in cases occurred from January to September 2025, with the post-intervention group representing 7.91% (133 patients) of CAP cases. The primary affected age shifted from 0–3 years pre- and during-intervention to 6–18 years post-intervention (H = 172.24, P not fully reported in supplied text). Post-intervention cases showed more severe imaging findings and higher rates of macrolide unresponsiveness.
Public-health relevance
Findings suggest a 'suppression-rebound' effect of NPIs on childhood Chlamydia pneumoniae pneumonia, with a shift toward school-aged children and implications for targeted school-based prevention and optimized antibiotic treatment.
Important limitations
This summary is limited to the supplied single-article abstract and metadata; the original paper is needed for decision-grade interpretation, including full statistical detail, potential confounders, and generalizability beyond a single Beijing pediatric center.
GIDS interpretation
The study describes the epidemiology and clinical profile of childhood Chlamydia pneumoniae pneumonia across intervention periods in Beijing; its discoverability is supported by disease and treatment classifiers, but it does not by itself confirm or refute any live surveillance signal.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 9 auditable classifier relationships to diseases, places, topics, and study design.